analytics_image
Hemophilia Market is expected to grow with a CAGR 5.3% from 2022 to 2028

Vantage Market Research

Blogs-Hemophilia Market is expected to grow with a CAGR 5.3% from 2022 to 2028

Vantage Market Research | 25 Jan 2022

Healthcare

Hemophilia Market is expected to grow with a CAGR 5.3% from 2022 to 2028

image

The Global Hemophilia Market accounted for USD 12.1 Billion in 2021.

The Global Hemophilia Market is mainly driven by, increasing demand for recombinant and plasma-derived factor VIII and factor IX. These are proteins, used in the treatment of 10;Additionally, increasing focus on prophylactic treatment, as well as increasing consumer healthcare expenditure along with the rising popularity of gene therapy is further propelling the market growth over the forecast period. In addition, factors such as increasing investment in R&D and increasing approval of drugs for treat of hemophilia are further fueling the market growth.

According to the Centers for Disease Control and Prevention (CDC), in the United States, around 30,000 and 33,000 males are living with hemophilia. The study estimates that, around 12 cases per 100,000 U.S. males for hemophilia A and 3.7 cases per 100,000 10;males for hemophilia B. Moreover, according to the estimates, among all births in the U.S., 1 birth per 5,617 male births is for hemophilia A, whereas; 1 birth per 19,283 male births for hemophilia B. Thus, as a result, the demand for hemophilia treatment further propelled the market growth over the forecast period.

Moreover, several governments, as well as major players, are investing their money heavily in Research and Developments (R&D) activities especially on identifying therapeutic agents. For instance, in July 2021- BioMarin Pharmaceutical 10;announced that the European Medicines Agency (EMA) validated the Company's Marketing Authorization Application (MAA) for its investigational gene therapy, valoctocogene roxaparvovec, for adults with severe hemophilia A. thus, increasing initiatives along with investments is anticipated to propel the market growth over the forecast period.

Additionally, increased diagnosis rate and rise in the use of prophylactic treatment for hemophilia are further projected to boost the Hemophilia Market growth over the forecast 10;However, the high cost of products, along with stringent government regulations may act as restrain and hamper the market growth.

North America held prominent market share for Hemophilia Market. The market growth is attributed to the presence of major players in the region. Also, increasing government initiatives and support in the region is further likely to propel market growth.

Some of the key players in the Hemophilia Market include - Shire (Baxalta); CSL Behring; Pfizer, Inc.; Bayer AG; BioMarin, Spark Therapeutics, Inc.; Genzyme Corporation; Chugai Pharmaceutical Co. Ltd.; Novo Nordisk A/S.; and Octapharma AG

Healthcare

Hemophilia Market is expected to grow with a CAGR 5.3% from 2022 to 2028

25 Jan 2022

Min Read

Historical Data | Base Year 

Add banner

star icon

Access Full Report

Cosmetic Ingredients Market - Global Industry Assessment (2022 - 2028)

This report by Vantage Market Research delivers comprehensive analysis of Somatostatin Analogs Market , focusing on Market Size, Share & Trends Analysis Report by Type (Octreotide, Lanreotide, Pasireotide) by Application (Acromegaly, Neuroendocrine Tumors (NETs), Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)

Request Sample

Related Reports

Healthcare

Veterinary Care Market Size, Share & Trends Analysis Report.

13 Nov 2023

10 Min Read

Healthcare

Surgical Imaging Market Size, Share & Trends Analysis Report.

13 Nov 2023

10 Min Read

Healthcare

Surgical Imaging Market Size, Share & Trends Analysis Report.

13 Nov 2023

10 Min Read

Latest Blogs

13 Nov 2023

Veterinary Care Market Size, Share & Trends Analysis Report.

Healthcare

13 Nov 2023

Surgical Imaging Market Size, Share & Trends Analysis Report.

Healthcare

13 Nov 2023

Surgical Imaging Market Size, Share & Trends Analysis Report.

Healthcare

vantage logo

Vantage Market Research & Consultancy Services is all about providing accurate and reliable market intelligence to its clients for the seamless execution of their business growth strategies.

© 2024 Vantage Market Research. All right reserved
Secured Bysecured by